Arrowhead Pharmaceuticals
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades
Arrowhead Pharmaceuticals shares surge following positive Phase 3 clinical trial results for its triglyceride lowering drug, plozasiran.
4 sources
5 articles
v 3
77d ago
◼ Archived
Business
🔮 fades
Arrowhead stock surges to multi-year highs following a major Phase 3 trial success, while chief rival Ionis falls.
8 sources
8 articles
v 6
78d ago
\n
\n
\n